Security key
52635N103
LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ)
CUSIP: 52635N103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 18,735,645
- Total 13F value
- $444,795,067
- Share change
- -134,092
- SEC-reported price per share
- $23.74
- Number of holders
- 78
- Value change
- -$1,423,016
- Number of buys
- 41
- Number of sells
- 23
- Shares outstanding
- 31,441,412
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
78
Top holders
10
LENZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
LENZ Therapeutics, Inc. SEC filings
LENZ Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52635N103
Recent filing periods:
Ownership snapshot
Top reported holders of LENZ - LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
13%
Alpha Wave Global, LP
11%
EcoR1 Capital, LLC
3.9%
Samsara BioCapital, LLC
3.8%
SECTORAL ASSET MANAGEMENT INC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
13%
|
$72,251,850
4,178,823 shares
|
— | 30 Jun 2024 |
| Alpha Wave Global, LP |
13F
Company
|
11%
|
$62,455,128
3,612,211 shares
|
— | 30 Jun 2024 |
| EcoR1 Capital, LLC |
3/4/5
13F
10%+ Owner · Company
|
3.9%
from 13F
|
$34,836,860
8,538,446 shares
|
— | 06 Jan 2023 |
| Samsara BioCapital, LLC |
13F
Company
|
3.8%
|
$20,894,498
1,208,473 shares
|
— | 30 Jun 2024 |
| SECTORAL ASSET MANAGEMENT INC |
13F
Company
|
3.4%
|
$18,749,345
1,084,404 shares
|
— | 30 Jun 2024 |
| 72 Investment Holdings, LLC |
13F
Company
|
3.2%
|
$17,596,915
1,017,751 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
18,735,645
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
63
Q3 2024 holders
78
Holder diff
15
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend